Skip to main content
. 2012 Feb 21;17(3):326–338. doi: 10.1634/theoncologist.2011-0356

Table 5.

Ongoing clinical trials in pancreatic neuroendocrine tumors and carcinoids

graphic file with name onc00312-1008-t05.jpg

Abbreviations: CALGB, Cancer and Leukemia Group B; CUH, Cambridge University Hospitals; DFCI, Dana Farber Cancer Institute; ECOG, Eastern Cooperative Oncology Group; FFCD, Federation Francophone de Cancerologie Digestive; IGF1, insulin-like growth factor 1; MSKCC, Memorial Sloan Kettering Cancer Center; NET, neuroendocrine tumor; PFS, progression-free survival; PNET, pancreatic neuroendocrine tumor; RR, response rate; SWOG, Southwest Oncology Group; TTP, time to progression.